COST-Aktionen offen für österreichische Beteiligungen im Bereich "Medical and Health Sciences"

Durch Anklicken der Nummer gelangen Sie zur entsprechenden COST-Aktion auf www.cost.eu
Nummer Titel
CA17101 European Network on Pseudomyxoma Peritonei
CA17103 Delivery of RNA therapy
CA17104 New diagnostic and therapeutic tools against multidrug resistant tumors
CA17112 PROSPECTIVE EUROPEAN DRUG-INDUCED LIVER INJURY NETWORK
CA17117 Towards an International Network for Evidence-based Research in Clinical Health Research
CA17118 IDENTIFYING BIOMARKERS THROUGH TRANSLATIONAL RESEARCH FOR PREVENTION AND STRATIFICATION OF COLORECTAL CANCER
CA17130 Enhancing Psychiatric Genetic Counselling, Testing, and Training in Europe
CA18103 Innovation with Glycans: new frontiers from synthesis to new biological targets
CA18106 The neural architecture of consciousness
CA18116 Aniridia: networking to address an unmet medical, scientific, and societal challenge
CA18117 European network for Gynaecological Rare Cancer research: From Concept to Cure
CA18208 Novel tools for test evaluation and disease prevalence estimation
CA18216 Network for Research in Vascular Ageing
CA18218 European Burden of Disease Network
CA18233 European Network for Innovative Diagnosis and Treatment of Chronic Neutropenias
CA18240 ADHEsion GPCR Network: Research and Implementation Set the path for future Exploration
CA19101 Determinants of Physical Activities in Settings
CA19104 advancing Social inclusion through Technology and EmPowerment
CA19106 Multi-Sectoral Responses to Child Abuse and Neglect in Europe: Incidence and Trends
CA19114 Network for Optimized Astatine labeled Radiopharmaceuticals
CA19115 Network for blood pressure research in children and adolescents
CA19127 Cognitive decline in Nephro-Neurology: European Cooperative Target
CA19132 European Network to Advance Best practices & technoLogy on medication adherencE
CA19137 Sudden cardiac arrest prediction and resuscitation network: Improving the quality of care
CA19138 Lobular Breast Cancer: Discovery Science, Translational Goals, Clinical Impact
CA20114 Therapeutical applications of Cold Plasmas
CA20119 European andrology network – research coordination, education and public awareness
CA20122 Harmonizing clinical care and research on adrenal tumours in European countries
CA20124 Maximising impact of multidisciplinary research in early diagnosis of neonatal brain injury
CA20135 Improving biomedical research by automated behaviour monitoring in the animal home-cage
CA21105 Blastocystis under One Health
CA21108 European Network for Skin Engineering and Modeling
CA21110 Building an open European Network on OsteoArthritis research
CA21111 One Health drugs against parasitic vector borne diseases in Europe and beyond
CA21113 Genome Editing to Treat Humans Diseases
CA21116 Identification of biological markers for prevention and translational medicine in pancreatic cancer
CA21117 The role of IMMUnity in tackling PARKinson’s disease through a Translational NETwork
CA21123 Cancer- Understanding Prevention in Intellectual Disabilities
CA21130 P2X receptors as a therapeutic opportunity
CA21132 European Swine Influenza Network
CA21135 Modelling immunotherapy response and toxicity in cancer
CA21137 Ethics in Dementia
CA21139 3Rs concepts to improve the quality of biomedical science
CA21140 INTercEption of oRal CancEr develoPmenT
CA21145 European Network for diagnosis and treatment of antibiotic-resistant bacterial infections
CA21147 European Network on Optimising Treatment with Therapeutic Antibodies in chronic inflammatory diseases
CA21149 Reducing acrylamide exposure of consumers by a cereals supply-chain approach targeting asparagine
CA21152 Implementation Network Europe for Cancer Survivorship Care
CA21153 Network for implementing multiomics approaches in atherosclerotic cardiovascular disease prevention and research
CA21164 TowArDs an improVement in diAgNostiCs and trEatment strategies for TB control
CA21165 Personalized medicine in chronic kidney disease: improved outcome based on Big Data
CA21168 Improving outcome of Juvenile Inflammatory Rheumatism via universally applicable clinical practice
CA21170 Prevention, anticipation and mitigation of tick-borne disease risk applying the DAMA protocol